Who invested in Histogenics?
Histogenics's investors include Sofinnova Investments, Split Rock Partners, BioMed Ventures, Flare Capital and Boston Millennia Partners.
United States · Series A startup
4 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$145Mraised across 4 rounds since 2008, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $37M sold, first sale Jul 2012
Reported by masshightech.comSEC filing: $37M sold, first sale Jul 2012
No investor was named in the report.
Reported by masshightech.comSEC filing: $34M sold, first sale May 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Histogenics's investors include Sofinnova Investments, Split Rock Partners, BioMed Ventures, Flare Capital and Boston Millennia Partners.
Histogenics has raised $145M across 4 rounds since 2008.
Histogenics's most recent round was a Series A of $49M in Jul 2012.
Histogenics's largest round on record is $49M (Series C), in Jul 2012.
Histogenics's first round on record, in Sept 2008, was backed by Flare Capital and Boston Millennia Partners.
Histogenics's latest named round is a Series A, in Jul 2012.
Histogenics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.